A rose by any other name…
If it were a Hollywood Blockbuster, instead of a Pharmaceutical Blockbuster, it would be called:
Return of the insulin-sensitizers
TZDs: the next generation
Insulin-sensitizers III, new blood.
If it were a commercial product, it might be re-branded as a new-and-improved insulin-sensitizer:
100% weight-gain free!
Now with less edema and death!
But this is a (potential) pharma blockbuster, so instead it’s called a mitochondrial target of thiazolidinedione modulator. Say what?
Read my report on the next potential game-changer in the medicine cabinet war against type 2 diabetes over a D’Mine. And don’t worry, instead of using crazy science talk about mitochondrial pyruvate carriers, I’m going to tell you how this drug fixes the microscopic cookie conveyor belts inside your cells.
Read all about it here.